标题:
抗VEGF治疗RVO合并的黄斑水肿的研究进展Study Progress of Unti-VEGF Treatment of Macular Edema Induced by Retinal Vein Occlusion
作者:
刘敏, 罗文娟
关键字:
黄斑水肿, 视网膜静脉阻塞, 抗VEGF治疗, 联合治疗Macular Edema, Retinal Vein Occlusion, Anti-VEGF Treatment, Combined Treatment
期刊名称:
《Hans Journal of Ophthalmology》, Vol.4 No.2, 2015-06-29
摘要:
视网膜静脉阻塞(retinal vein occlusion, RVO)是仅次于糖尿病性视网膜病变的常见视网膜血管疾病,是致盲的主要原因之一。黄斑水肿(macular edema)是RVO视力损害的最主要的原因。因此黄斑水肿的治疗是RVO治疗中最重要的内容，近年来抗VEGF药物的出现为黄斑水肿的治疗提供了一种新的治疗手段，目前大量研究证实无论是在消除或者减轻黄斑水肿方面，还是在提高视力方面，玻璃体腔内注射抗VEGF药物治疗RVO黄斑水肿都是有确切疗效的。本文就近年来有关RVO合并的黄斑水肿的抗VEGF治疗研究进展综述如下。Retinal vein occlusion (RVO) is a common disease to cause blindness, which incidence is only next to diabetic retinopathy. The macular edema is the cause of vision loses. Therefore, the treatment of macular edema is one of the most important contents of RVO treatment. In recent years, the emergence of anti-VEGF drugs for the treatment of macular edema provides a new method. At present, a large of studies confirm whether in terms of eliminate or relieve the macular edema, or in terms of improving eyesight. Vitreous injection of anti-VEGF drug has exact curative effect. This paper reviews the recent advances in anti-VEGF treatment of macular edema secondary to retinal vein occlusion.